Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Follow us on Twitter

  • The Food and Drug Administration has authorized a clinical trial of stem cells extracted and cultured from patients… https://t.co/68QuQj2ik5
    about 8 hours ago
  • New post on Science and Enterprise: FDA Clears Stem Cell Trial for Multiple Sclerosis https://t.co/iLohWcDKEC #Science #Business
    about 8 hours ago
  • A venture philanthropy group is funding an initiative to find digital data indicators of early onset of Alzheimer's… https://t.co/YBoAZKBjBw
    about 1 day ago
  • New post on Science and Enterprise: Alzheimer’s Digital Biomarkers Project Gains New Funds https://t.co/lxhfwd4Bzi #Science #Business
    about 1 day ago
  • Shionogi starts clinical test on oral COVID drug | NHK WORLD-JAPAN News https://t.co/EAQvk9nGjw
    about 2 days ago

Please share Science & Enterprise

Synthetic Blood Vessel Maker Gains $2.2M in Seed Funds

Red blood cells illustration

A start-up company creating synthetic blood vessels for transplants, based on research in materials science and cell biology, is raising $2.2 million in seed funds. . . . → Read More: Synthetic Blood Vessel Maker Gains $2.2M in Seed Funds

Neuro Disease Start-Up Raises $73M in Early Funds

Nerve cells illustration

A new enterprise discovering treatments for neurodegenerative diseases is merging with another start-up and raising $73 million its first venture round. . . . → Read More: Neuro Disease Start-Up Raises $73M in Early Funds

Microbiome Drug Candidate Licensed in $525M Deal

C. difficile in petri dish

A therapy designed to regenerate healthy gut microbes for treating dangerous intestinal infections is licensed for commercialization to Nestlé Health Science. . . . → Read More: Microbiome Drug Candidate Licensed in $525M Deal

Biotechs Partner on Crispr Therapies for Neuro Disorders

Adeno-associated virus

Two biotechnology companies are designing therapies to deliver edited genes to treat Friedreich’s ataxia and amyotrophic lateral sclerosis, or ALS. . . . → Read More: Biotechs Partner on Crispr Therapies for Neuro Disorders

Plant-Based Lipids Developed for mRNA Vaccines

Vesicles

Chemists at industry and academic labs created safer lipids for delivering messenger RNA vaccines, such as those protecting against Covid-19. . . . → Read More: Plant-Based Lipids Developed for mRNA Vaccines

Biotechs Partner on Gene-Edited Cancer Cell Therapies

Natural killer cell

Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immune-system cells to treat cancer. . . . → Read More: Biotechs Partner on Gene-Edited Cancer Cell Therapies

Moderna Supplying 500M Vaccine Doses to Covax

Vaccine delivery to Philippines

Moderna Inc. is providing up to 500 million doses of its Covid-19 vaccine to the Covax Facility, an international project distributing vaccines to low-income countries. . . . → Read More: Moderna Supplying 500M Vaccine Doses to Covax

Vaccine Stops Lyme Bacteria in Preclinical Test

Adult deer tick

A study with lab mice shows an experimental vaccine with engineered bacteria produces antibodies and protects against microbes causing Lyme disease. . . . → Read More: Vaccine Stops Lyme Bacteria in Preclinical Test

NIH Trial Testing mRNA Vaccine Allergic Effects

Syringe

A clinical trial is underway testing for allergic reactions to Covid-19 vaccines using messenger RNA for invoking an immune response. . . . → Read More: NIH Trial Testing mRNA Vaccine Allergic Effects

Trial Shows Inhaled Covid-19 Therapy Safe

Nasal spray

Results of a clinical trial show an anti-microbial treatment for Covid-19 infections given as a nasal spray is safe and well-tolerated in healthy volunteers. . . . → Read More: Trial Shows Inhaled Covid-19 Therapy Safe